Skip to content

USNA

USANA HEALTH SCIENCES INC

NYSE · Consumer Defensive · Packaged Foods · US

$14.22
−4.37%
Ask drillr

Year over year

Reported trailing growth

Revenue
-0.8%
EBITDA
-65.6%
EBIT
-76.9%
EPS
—
Free cash flow
-54.4%
Operating cash flow
-29.1%

Forward estimates

Based on analyst estimates

Revenue
+3.2%
EBITDA
+126.2%
EPS
+220.3%

Three-year CAGR

Revenue
-2.5%
EBITDA
-14.3%
EBIT
-22.1%
Net income
-46.3%
EPS
-45.6%
Free cash flow
-55.0%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Oct 1, 2026